Intco Medical Stock Hits Day Low of CNY 57.70 Amid Price Pressure

Intco Medical Technology Co., Ltd. experienced a notable decline today, with the stock dropping by 5.65% on March 16, 2026. The stock reached an intraday low of CNY 57.70, reflecting a significant shift in market activity. Despite this downturn, the company has shown strong performance metrics over various time frames. In the past year, Intco Medical has generated an impressive return of 136.61%, significantly outperforming the China Shanghai Composite, which recorded a gain of 19.45%. The company's year-to-date performance stands at 49.87%, again surpassing the broader market's 2.92%. Financially, Intco Medical boasts a robust operating cash flow of CNY 2,119.78 million and a return on capital employed (ROCE) of 9.77%. The company's price-to-book ratio is 1.37, indicating an attractive valuation. Additionally, the firm has maintained a high dividend yield of 0.39%, further enhancing its financial appeal. Overall, while today's trading session reflects a dip in stock price, Intco Medical continues to demonstrate strong fundamentals and a solid market position within the pharmaceuticals and biotechnology sector.